Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chromosome 17 abnormalities and inactivation of the p53 gene in chronic myeloid leukemia and their prognostic significance.

Leukemia & lymphoma - 1 Oct 1995

Nakai H, Misawa S

Abstract excerpt

We have reviewed all the relevant studies on the loss of the short arm of chromosome 17 (17p) and inactivation of the p53 gene in chronic myelogenous leukemia (CML) in an attempt to clarify their roles in the progression of CML. Loss of a 17p (hemizygous 17p) and p53 inactivation emerged as the disease progressed and were closely associated with each other. About half of the cases with loss of a 17p, however, did...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosome Aberrations
Share to Chromosome Deletion
Share to Chromosome Disorders

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Chromosomes, Human, Pair 17

Share to Genes, p53

Share to Phenotype

Share to Prognosis

Share to Survival Analysis

Source

Identifiers

PMID: 8535212
DOI: 10.3109/10428199509107891

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chromosome 17 abnormalities and inactivation of the p53 gene in chronic myeloid leukemia and their prognostic significance.PMID 8535212Read ↗

Prognostic significance of loss of a chromosome 17p and p53 gene mutations in blast crisis of chronic myelogenous leukaemia.Semantic proximity Read ↗

p53 in chronic myelogenous leukemia in acute phase.Semantic proximity Read ↗

Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.Semantic proximity Read ↗

17p deletion in chronic lymphocytic leukemia: risk stratification and therapeutic approach.Semantic proximity Read ↗

Analysis of the p53 gene mutations in acute myelogenous leukemia: the p53 gene mutations associated with a deletion of chromosome 17.Semantic proximity Read ↗

Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia.Semantic proximity Read ↗

Chromosome abnormalities with prognostic impact in B-cell chronic lymphocytic leukemia.Semantic proximity Read ↗

Chronic lymphocytic leukemia with isochromosome 17q: An aggressive subgroup associated with TP53 mutations and complex karyotypes.Semantic proximity Read ↗

Chronic lymphocytic leukemia and treatment resistance in cancer: The role of the p53 pathwaySemantic proximity Read ↗

Identification of a commonly deleted region at 17p13.3 in leukemia and lymphoma associated with 17p abnormality.Semantic proximity Read ↗

Treatment resistance in chronic lymphocytic leukemia–the role of the p53 pathwaySemantic proximity Read ↗

Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.